{"id":84087,"date":"2026-02-19T16:32:23","date_gmt":"2026-02-19T16:32:23","guid":{"rendered":"https:\/\/www.cofb.org\/?p=84087"},"modified":"2026-02-23T16:34:48","modified_gmt":"2026-02-23T16:34:48","slug":"ultimes-novetats-en-oftalmologia-en-lambit-de-la-farmacia-hospitalaria","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2026\/02\/19\/ultimes-novetats-en-oftalmologia-en-lambit-de-la-farmacia-hospitalaria\/","title":{"rendered":"\u00daltimes novetats en oftalmologia en l’\u00e0mbit de la farm\u00e0cia hospital\u00e0ria"},"content":{"rendered":"\n

El passat 12 de febrer, al Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB)<\/strong> es va celebrar la sessi\u00f3 \u201cActualitzaci\u00f3 en Oftalmologia<\/strong>\u201d, amb el patrocini d\u2019Amgen<\/a>. La formaci\u00f3 va comptar amb la participaci\u00f3 de Santiago Grau<\/strong>, farmac\u00e8utic i director de l\u2019\u00c0rea del Medicament de l\u2019Hospital del Mar, Isaac Alarc\u00f3n<\/strong>, oftalm\u00f2leg, especialista en retina i uve\u00eftis i cap de secci\u00f3 del Servei d\u2019Oftalmologia de l\u2019Hospital del Mar, Marta Roig<\/strong>, farmac\u00e8utica i directora de l\u2019\u00c0rea del Medicament del Consorci Sanitari de Barcelona, Ferran Mascar\u00f3<\/strong>, oftalm\u00f2leg del Servei d\u2019oftalmologia de l\u2019Hospital de Bellvitge i Miguel \u00c1ngel Zapata<\/strong>, oftalm\u00f2leg, especialista en retina i cap de servei d\u2019oftalmologia de l\u2019Hospital Vall d\u2019Hebron. Anna Heredia<\/strong>, cap del Departament de Formaci\u00f3 i Relacions Institucionals, va moderar la formaci\u00f3.<\/p>\n\n\n\n

Els objectius <\/strong>de la confer\u00e8ncia, adre\u00e7ada a farmac\u00e8utics\/ques d\u2019hospital, van ser revisar patologies oft\u00e0lmiques<\/strong> de tractament hospitalari, actualitzar els coneixements sobre nous tractaments, tecnologies de diagn\u00f2stic i protocols de manipulaci\u00f3 <\/strong>segura dels tractaments per a les patologies oft\u00e0lmiques, valorar l\u2019impacte de la implementaci\u00f3 cl\u00ednica de la IA<\/strong> i potenciar el rol del farmac\u00e8utic hospitalari <\/strong>en el maneig de la farmacologia de les patologies oft\u00e0lmiques. <\/p>\n\n\n\n

Ter\u00e0pia oftalmol\u00f2gica: una realitat actual i un repte pel futur<\/h2>\n\n\n\n

Pel que fa a la ter\u00e0pia oftalmol\u00f2gica ambulat\u00f2ria<\/strong>, Santiago Grau va afirmar que \u201c\u00e9s un nou camp a explorar amb importants reptes a futur, com l\u2019estudi en vida real del comportament de les diferents mol\u00e8cules disponibles<\/strong>. Un altre aspecte \u00e9s augmentar el coneixement sobre quin \u00e9s el millor maneig d\u2019aquests f\u00e0rmacs per garantir la seva efic\u00e0cia i la seva seguretat\u201d.<\/p>\n\n\n\n

\"El<\/a>
El director de l\u2019\u00c0rea del Medicament de l\u2019Hospital del Mar, Santiago Grau, durant la seva presentaci\u00f3 lligada a ter\u00e0pia oftalmol\u00f2gica.<\/figcaption><\/figure>\n\n\n\n

En aquest sentit, el director de l\u2019\u00c0rea del Medicament de l\u2019Hospital del Mar va defensar \u201cpromoure la formaci\u00f3 d\u2019equips de treball<\/strong> amb els diferents perfils de professionals implicats en l\u2019atenci\u00f3 a pacients amb afeccions oculars que requereixen aquestes ter\u00e0pies\u201d. Finalment, Grau va analitzar diferents estudis i assajos cl\u00ednics <\/strong>realitzats recentment per destacar les principals innovacions i conclusions extretes pels diferents experts, i que permeten continuar fent passos cap a millorar la ter\u00e0pia oftalmol\u00f2gica.<\/p>\n\n\n\n

Patologia m\u00e8dica de la retina<\/h2>\n\n\n\n

Amb relaci\u00f3 a l\u2019actualitzaci\u00f3 en patologia m\u00e8dica de la retina, Isaac Alarc\u00f3n<\/strong> va destacar que la Degeneraci\u00f3 Macular Associada a l\u2019Edat <\/strong>(DMAE) \u201c\u00e9s una malaltia cr\u00f2nica i progressiva de la m\u00e0cula i una de les principals causes de deteriorament de la visi\u00f3 central en les persones majors de 50 anys. Es preveu que la prevalen\u00e7a<\/strong> de DMAE augmenti en tot el m\u00f3n fins a 288 milions en 2040\u201d.<\/p>\n\n\n\n

Pel que fa als factors de risc que poden augmentar les possibilitats de desenvolupar aquesta malaltia<\/strong>, el cap de secci\u00f3 del Servei d\u2019Oftalmologia de l\u2019Hospital del Mar va explicar que \u201caugmenta amb l\u2019edat, amb un r\u00e0pid augment de la DMAE avan\u00e7ada en les persones de m\u00e9s de 75 anys”. Per altra banda, el ponent va compartir que “les persones que tenen un germ\u00e0 amb DMAE augmenten per quatre el risc de desenvolupar-la. Fumar duplica el risc de DMAE, junt amb altres factors d\u2019estil de vida, com una dieta deficient o falta d\u2019exercici\u201d.<\/p>\n\n\n\n

\"L'oftalm\u00f2leg<\/a>
L’oftalm\u00f2leg Isaac Alarc\u00f3n en un moment del curs “Actualizaci\u00f3 en Oftalmologia”.<\/figcaption><\/figure>\n\n\n\n

Pel que fa als s\u00edmptomes, \u201cel primer sol ser una \u00e0rea borrosa o distorsionada de la visi\u00f3<\/strong>. La DMA mitjana tamb\u00e9 pot alterar la visi\u00f3 nocturna, i en la DMA avan\u00e7ada, pot existir una p\u00e8rdua de la visi\u00f3 central, aix\u00ed com dels s\u00edmptomes addicionals com l\u00ednies rectes ondulades i tor\u00e7ades, objectes que semblen m\u00e9s petits, colors menys brillants i fins i tot al\u00b7lucinacions\u201d. Alarc\u00f3n va afirmar que la DMAE \u201c\u00e9s una de les principals causes del deteriorament de la visi\u00f3 central <\/strong>en les persones majors de 50 anys. Aix\u00ed doncs, s\u00f3n necessaris nous tractaments dirigits a millorar la durabilitat per reduir la c\u00e0rrega terap\u00e8utica dels pacients\u201d.<\/p>\n\n\n\n

Per concloure, va fer menci\u00f3 a la retinopatia diab\u00e8tica<\/strong> i l‘edema macular diab\u00e8tic<\/strong>, afirmant que “tenen un enorme impacte en la salut p\u00fablica mundial al futur. A m\u00e9s, la diabetes mellitus s’associa amb el desenvolupament de complicacions oculars”. Finalment, l’oftalm\u00f2leg va fer menci\u00f3 als futurs tractaments de la patologia m\u00e8dica de la retina<\/strong>.<\/p>\n\n\n\n

La malaltia ocular tiroide<\/h2>\n\n\n\n

Ferran Mascar\u00f3<\/strong> es va centrar en la malaltia ocular tiroide (TED), enumerant les noves ter\u00e0pies que han anat apareixent amb el pas dels anys com el Rituximab, Tocilizumab o el Teprotumumab. A m\u00e9s, va assenyalar que \u201cmai \u00e9s tard per deixar de fumar, un clar factor de risc envers aquesta malaltia, en qu\u00e8 el tractament de primera l\u00ednia<\/strong> encara s\u00f3n els corticoides<\/strong>\u201d.<\/p>\n\n\n\n

\"Ferran<\/a>
Ferran Mascar\u00f3, oftalm\u00f2leg de l’Hospital de Bellvitge, va analitzar la malaltia ocular tiroide.<\/figcaption><\/figure>\n\n\n\n

A continuaci\u00f3, l\u2019oftalm\u00f2leg de l\u2019Hospital de Bellvitge va descriure com s\u2019havia de descomprimir la TED<\/strong>, comen\u00e7ant per realitzar una incisi\u00f3, seguint per la dissecci\u00f3, sutures, l\u2019aixecament del periosti i acabant amb l\u2019obertura de la peri\u00f2rbita i la sutura per plans. El pacient amb aquesta malaltia m\u00e9s complex de ser tractat \u00e9s \u201cel que pateix una TED activa greu,<\/strong> retropulsi\u00f3 p\u00e8tria, parets laterals curtes i grans, fumador, de sexe mascul\u00ed i amb molta asimetria\u201d.<\/p>\n\n\n\n

MHDA i la ter\u00e0pia oft\u00e0lmica<\/h2>\n\n\n\n

Marta Roig<\/strong> va presentar una mirada en la ter\u00e0pia oft\u00e0lmica dins els medicaments hospitalaris de dispensaci\u00f3 ambulat\u00f2ria<\/strong> (MHDA) des d\u2019un aspecte m\u00e9s regulador, centrant-se en l\u2019administraci\u00f3 sanit\u00e0ria<\/strong> i l\u2019impacte que t\u00e9 sobre la gesti\u00f3 d\u2019aquest grup de tractaments: enfront de les malalties que afecten els ulls, existeixen actualment anticossos monoclonals, monocatenaris <\/strong>i biespec\u00edfics<\/strong>.<\/p>\n\n\n\n

\"Marta<\/a>
Marta Roig, farmac\u00e8utica i directora de l\u2019\u00c0rea del Medicament del Consorci Sanitari de Barcelona, durant la seva exposici\u00f3.<\/figcaption><\/figure>\n\n\n\n

Un dels missatges claus defensats per la directora de l\u2019\u00c0rea del Medicament del Consorci Sanitari de Barcelona va ser que aquests f\u00e0rmacs \u201ctracten patologies d\u2019alt impacte cl\u00ednic i funcional<\/strong>, amb una elevada c\u00e0rrega assistencial i de despeses pel sistema\u201d.<\/p>\n\n\n\n

Pel que fa a les estrat\u00e8gies implementades fins ara, \u201cs\u2019han establert administracions en xeringues precarregades<\/strong>, l\u2019aparici\u00f3 de bio similars, nous mecanismes d\u2019acci\u00f3 <\/strong>i augment de l\u2019efecte, reduint la c\u00e0rrega assistencial i millorant l\u2019adher\u00e8ncia\u201d. Amb relaci\u00f3 als reptes, Roig va destacar \u201cla cronificaci\u00f3 del tractament<\/strong>, la capacitat assistencial <\/strong>i la incorporaci\u00f3 de noves ter\u00e0pie<\/strong>s\u201d.<\/p>\n\n\n\n

IA aplicada a l\u2019avaluaci\u00f3 dels tractaments de les malalties oftalmol\u00f2giques<\/h2>\n\n\n\n

Miguel \u00c1ngel Zapata <\/strong>va analitzar la intel\u00b7lig\u00e8ncia artificial aplicada<\/strong> a l\u2019avaluaci\u00f3 dels tractaments de les malalties oftalmol\u00f2giques: \u201cla nova llei d\u2019intel\u00b7lig\u00e8ncia artificial de la Uni\u00f3 Europea en l\u2019\u00fas m\u00e8dic exigeix tra\u00e7abilitat de les explicacions, supervisi\u00f3 humana adequada, gesti\u00f3 del risc cr\u00edtic i auditories i vigil\u00e0ncia postcomercialitzaci\u00f3<\/strong>\u201d.<\/p>\n\n\n\n

\"Miguel<\/a>
Miguel \u00c1ngel Zapata, cap de servei d’Oftalmologia de l’Hospital Vall d’Hebron, en un moment de la seva intervenci\u00f3<\/figcaption><\/figure>\n\n\n\n

Amb relaci\u00f3 a la responsabilitat i a la pr\u00e0ctica cl\u00ednica, \u201cel professional i la instituci\u00f3 que utilitzi aquesta tecnologia ha d\u2019usar el sistema segons les indicacions aprovades. En el cas d\u2019\u00fas aut\u00f2nom perm\u00e8s, la responsabilitat principal recau en el fabricant, no en el professional\u201d.<\/p>\n\n\n\n

Per finalitzar, el cap de servei d\u2019Oftalmologia de l\u2019Hospital Vall d\u2019Hebron va analitzar diferents investigacions cl\u00edniques<\/strong> que analitzaven fins a quin punt la intel\u00b7lig\u00e8ncia artificial era capa\u00e7 de fer diagn\u00f2stics predictius<\/strong> en diferents casos cl\u00ednics.<\/p>\n\n\n\n

Amb el patrocini de:<\/strong><\/p>\n\n\n\n

\"\"<\/a><\/figure>\n","protected":false},"excerpt":{"rendered":"

El passat 12 de febrer, al Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) es va celebrar la sessi\u00f3 \u201cActualitzaci\u00f3 en Oftalmologia\u201d, amb el patrocini d\u2019Amgen. La formaci\u00f3 va comptar amb la participaci\u00f3 de Santiago Grau, farmac\u00e8utic i director de l\u2019\u00c0rea del Medicament de l\u2019Hospital del Mar, Isaac Alarc\u00f3n, oftalm\u00f2leg, especialista en […]<\/p>\n","protected":false},"author":10,"featured_media":84209,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,57],"tags":[18,19,53,480,70,5455,2770,104,5454,5117,752],"class_list":["post-84087","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-mon-collegial","tag-cofb","tag-collegi-de-farmaceutics-de-barcelona","tag-farmaceutics","tag-farmacia-hospitalaria","tag-formacio","tag-malaltia-ocular","tag-oftalmologia","tag-patologies","tag-retina","tag-servei-de-farmacia-hospitalaria","tag-terapia"],"yoast_head":"\n\u00daltimes novetats en oftalmologia en l'\u00e0mbit de la farm\u00e0cia hospital\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"description\" content=\"El passat 12 de febrer, el COFB va organitzar la confer\u00e8ncia \u201cActualitzaci\u00f3 en Oftalmologia\u201d, amb la col\u00b7laboraci\u00f3 d'Amgen.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cofb.org\/ca\/2026\/02\/19\/ultimes-novetats-en-oftalmologia-en-lambit-de-la-farmacia-hospitalaria\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u00daltimes novetats en oftalmologia en l'\u00e0mbit de la farm\u00e0cia hospital\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El passat 12 de febrer, el COFB va organitzar la confer\u00e8ncia \u201cActualitzaci\u00f3 en Oftalmologia\u201d, amb la col\u00b7laboraci\u00f3 d'Amgen.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cofb.org\/ca\/2026\/02\/19\/ultimes-novetats-en-oftalmologia-en-lambit-de-la-farmacia-hospitalaria\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-19T16:32:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-23T16:34:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/02\/Oftalmologia-2025_destacada-1-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1440\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Xavier Magraner\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"Xavier Magraner\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.cofb.org\/2026\/02\/19\/ultimes-novetats-en-oftalmologia-en-lambit-de-la-farmacia-hospitalaria\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/2026\/02\/19\/ultimes-novetats-en-oftalmologia-en-lambit-de-la-farmacia-hospitalaria\/\"},\"author\":{\"name\":\"Xavier Magraner\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/e46d741cfb92c985a083d163d8270ae4\"},\"headline\":\"\u00daltimes novetats en oftalmologia en l’\u00e0mbit de la farm\u00e0cia hospital\u00e0ria\",\"datePublished\":\"2026-02-19T16:32:23+00:00\",\"dateModified\":\"2026-02-23T16:34:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.cofb.org\/2026\/02\/19\/ultimes-novetats-en-oftalmologia-en-lambit-de-la-farmacia-hospitalaria\/\"},\"wordCount\":1337,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/2026\/02\/19\/ultimes-novetats-en-oftalmologia-en-lambit-de-la-farmacia-hospitalaria\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/02\/Oftalmologia-2025_destacada-1-scaled.jpg\",\"keywords\":[\"COFB\",\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"farmac\u00e8utics\",\"farm\u00e0cia hospital\u00e0ria\",\"Formaci\u00f3\",\"malaltia ocular\",\"oftalmologia\",\"patologies\",\"retina\",\"Servei de Farm\u00e0cia Hospital\u00e0ria\",\"ter\u00e0pia\"],\"articleSection\":[\"Destacats\",\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cofb.org\/2026\/02\/19\/ultimes-novetats-en-oftalmologia-en-lambit-de-la-farmacia-hospitalaria\/\",\"url\":\"https:\/\/www.cofb.org\/2026\/02\/19\/ultimes-novetats-en-oftalmologia-en-lambit-de-la-farmacia-hospitalaria\/\",\"name\":\"\u00daltimes novetats en oftalmologia en l'\u00e0mbit de la farm\u00e0cia hospital\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cofb.org\/2026\/02\/19\/ultimes-novetats-en-oftalmologia-en-lambit-de-la-farmacia-hospitalaria\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/2026\/02\/19\/ultimes-novetats-en-oftalmologia-en-lambit-de-la-farmacia-hospitalaria\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/02\/Oftalmologia-2025_destacada-1-scaled.jpg\",\"datePublished\":\"2026-02-19T16:32:23+00:00\",\"dateModified\":\"2026-02-23T16:34:48+00:00\",\"description\":\"El passat 12 de febrer, el COFB va organitzar la confer\u00e8ncia \u201cActualitzaci\u00f3 en Oftalmologia\u201d, amb la col\u00b7laboraci\u00f3 d'Amgen.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cofb.org\/2026\/02\/19\/ultimes-novetats-en-oftalmologia-en-lambit-de-la-farmacia-hospitalaria\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cofb.org\/2026\/02\/19\/ultimes-novetats-en-oftalmologia-en-lambit-de-la-farmacia-hospitalaria\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/2026\/02\/19\/ultimes-novetats-en-oftalmologia-en-lambit-de-la-farmacia-hospitalaria\/#primaryimage\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/02\/Oftalmologia-2025_destacada-1-scaled.jpg\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/02\/Oftalmologia-2025_destacada-1-scaled.jpg\",\"width\":2560,\"height\":1440,\"caption\":\"Eye exam in clinic\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cofb.org\/2026\/02\/19\/ultimes-novetats-en-oftalmologia-en-lambit-de-la-farmacia-hospitalaria\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u00daltimes novetats en oftalmologia en l’\u00e0mbit de la farm\u00e0cia hospital\u00e0ria\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/e46d741cfb92c985a083d163d8270ae4\",\"name\":\"Xavier Magraner\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/aa0d1d4df59f71f88eebd5796c5388ff41c58d83c5301eb6e1d65646a289c37d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/aa0d1d4df59f71f88eebd5796c5388ff41c58d83c5301eb6e1d65646a289c37d?s=96&d=mm&r=g\",\"caption\":\"Xavier Magraner\"},\"url\":\"https:\/\/www.cofb.org\/ca\/author\/xmagraner\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u00daltimes novetats en oftalmologia en l'\u00e0mbit de la farm\u00e0cia hospital\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"El passat 12 de febrer, el COFB va organitzar la confer\u00e8ncia \u201cActualitzaci\u00f3 en Oftalmologia\u201d, amb la col\u00b7laboraci\u00f3 d'Amgen.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cofb.org\/ca\/2026\/02\/19\/ultimes-novetats-en-oftalmologia-en-lambit-de-la-farmacia-hospitalaria\/","og_locale":"ca_ES","og_type":"article","og_title":"\u00daltimes novetats en oftalmologia en l'\u00e0mbit de la farm\u00e0cia hospital\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El passat 12 de febrer, el COFB va organitzar la confer\u00e8ncia \u201cActualitzaci\u00f3 en Oftalmologia\u201d, amb la col\u00b7laboraci\u00f3 d'Amgen.","og_url":"https:\/\/www.cofb.org\/ca\/2026\/02\/19\/ultimes-novetats-en-oftalmologia-en-lambit-de-la-farmacia-hospitalaria\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2026-02-19T16:32:23+00:00","article_modified_time":"2026-02-23T16:34:48+00:00","og_image":[{"width":2560,"height":1440,"url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/02\/Oftalmologia-2025_destacada-1-scaled.jpg","type":"image\/jpeg"}],"author":"Xavier Magraner","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"Xavier Magraner","Temps estimat de lectura":"8 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cofb.org\/2026\/02\/19\/ultimes-novetats-en-oftalmologia-en-lambit-de-la-farmacia-hospitalaria\/#article","isPartOf":{"@id":"https:\/\/www.cofb.org\/2026\/02\/19\/ultimes-novetats-en-oftalmologia-en-lambit-de-la-farmacia-hospitalaria\/"},"author":{"name":"Xavier Magraner","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/e46d741cfb92c985a083d163d8270ae4"},"headline":"\u00daltimes novetats en oftalmologia en l’\u00e0mbit de la farm\u00e0cia hospital\u00e0ria","datePublished":"2026-02-19T16:32:23+00:00","dateModified":"2026-02-23T16:34:48+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cofb.org\/2026\/02\/19\/ultimes-novetats-en-oftalmologia-en-lambit-de-la-farmacia-hospitalaria\/"},"wordCount":1337,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/www.cofb.org\/2026\/02\/19\/ultimes-novetats-en-oftalmologia-en-lambit-de-la-farmacia-hospitalaria\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/02\/Oftalmologia-2025_destacada-1-scaled.jpg","keywords":["COFB","Col\u00b7legi de Farmac\u00e8utics de Barcelona","farmac\u00e8utics","farm\u00e0cia hospital\u00e0ria","Formaci\u00f3","malaltia ocular","oftalmologia","patologies","retina","Servei de Farm\u00e0cia Hospital\u00e0ria","ter\u00e0pia"],"articleSection":["Destacats","M\u00f3n col\u00b7legial"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/www.cofb.org\/2026\/02\/19\/ultimes-novetats-en-oftalmologia-en-lambit-de-la-farmacia-hospitalaria\/","url":"https:\/\/www.cofb.org\/2026\/02\/19\/ultimes-novetats-en-oftalmologia-en-lambit-de-la-farmacia-hospitalaria\/","name":"\u00daltimes novetats en oftalmologia en l'\u00e0mbit de la farm\u00e0cia hospital\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cofb.org\/2026\/02\/19\/ultimes-novetats-en-oftalmologia-en-lambit-de-la-farmacia-hospitalaria\/#primaryimage"},"image":{"@id":"https:\/\/www.cofb.org\/2026\/02\/19\/ultimes-novetats-en-oftalmologia-en-lambit-de-la-farmacia-hospitalaria\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/02\/Oftalmologia-2025_destacada-1-scaled.jpg","datePublished":"2026-02-19T16:32:23+00:00","dateModified":"2026-02-23T16:34:48+00:00","description":"El passat 12 de febrer, el COFB va organitzar la confer\u00e8ncia \u201cActualitzaci\u00f3 en Oftalmologia\u201d, amb la col\u00b7laboraci\u00f3 d'Amgen.","breadcrumb":{"@id":"https:\/\/www.cofb.org\/2026\/02\/19\/ultimes-novetats-en-oftalmologia-en-lambit-de-la-farmacia-hospitalaria\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cofb.org\/2026\/02\/19\/ultimes-novetats-en-oftalmologia-en-lambit-de-la-farmacia-hospitalaria\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/2026\/02\/19\/ultimes-novetats-en-oftalmologia-en-lambit-de-la-farmacia-hospitalaria\/#primaryimage","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/02\/Oftalmologia-2025_destacada-1-scaled.jpg","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/02\/Oftalmologia-2025_destacada-1-scaled.jpg","width":2560,"height":1440,"caption":"Eye exam in clinic"},{"@type":"BreadcrumbList","@id":"https:\/\/www.cofb.org\/2026\/02\/19\/ultimes-novetats-en-oftalmologia-en-lambit-de-la-farmacia-hospitalaria\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"\u00daltimes novetats en oftalmologia en l’\u00e0mbit de la farm\u00e0cia hospital\u00e0ria"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/e46d741cfb92c985a083d163d8270ae4","name":"Xavier Magraner","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/aa0d1d4df59f71f88eebd5796c5388ff41c58d83c5301eb6e1d65646a289c37d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/aa0d1d4df59f71f88eebd5796c5388ff41c58d83c5301eb6e1d65646a289c37d?s=96&d=mm&r=g","caption":"Xavier Magraner"},"url":"https:\/\/www.cofb.org\/ca\/author\/xmagraner\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/02\/Oftalmologia-2025_destacada-1-scaled.jpg",2560,1440,false],"thumbnail":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/02\/Oftalmologia-2025_destacada-1-150x150.jpg",150,150,true],"medium":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/02\/Oftalmologia-2025_destacada-1-300x169.jpg",300,169,true],"medium_large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/02\/Oftalmologia-2025_destacada-1-768x432.jpg",768,432,true],"large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/02\/Oftalmologia-2025_destacada-1-1024x576.jpg",1024,576,true],"1536x1536":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/02\/Oftalmologia-2025_destacada-1-1536x864.jpg",1536,864,true],"2048x2048":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/02\/Oftalmologia-2025_destacada-1-2048x1152.jpg",2048,1152,true],"trp-custom-language-flag":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/02\/Oftalmologia-2025_destacada-1-18x10.jpg",18,10,true]},"uagb_author_info":{"display_name":"Xavier Magraner","author_link":"https:\/\/www.cofb.org\/ca\/author\/xmagraner\/"},"uagb_comment_info":0,"uagb_excerpt":"El passat 12 de febrer, al Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) es va celebrar la sessi\u00f3 \u201cActualitzaci\u00f3 en Oftalmologia\u201d, amb el patrocini d\u2019Amgen. La formaci\u00f3 va comptar amb la participaci\u00f3 de Santiago Grau, farmac\u00e8utic i director de l\u2019\u00c0rea del Medicament de l\u2019Hospital del Mar, Isaac Alarc\u00f3n, oftalm\u00f2leg, especialista en […]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/84087","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=84087"}],"version-history":[{"count":28,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/84087\/revisions"}],"predecessor-version":[{"id":84215,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/84087\/revisions\/84215"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media\/84209"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=84087"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=84087"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=84087"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}